From 2D to 3D - A new dimension for modelling the effect of natural products on human tissue

Current Pharmaceutical Design

Volumn 21, Issue 38, 2015, Pages 5605-5616

  Wrzesinski, Krzysztof ^a   Fey, Stephen J ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

3D cell culture; Bioreactor; Efficacy; Metabolic equilibrium; Natural products; Physiology; Spheroids; Toxicology

Indexed keywords

CELL PROTEIN; NATURAL PRODUCT; BIOLOGICAL PRODUCT;

APOPTOSIS; CACO 2 CELL LINE; CARDIOTOXICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTACT INHIBITION; CULTURE VESSEL; EXTRACELLULAR MATRIX; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; LUNG TOXICITY; MDCK CELL LINE; MECHANICAL STRESS; MICROGRAVITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SAOS 2 CELL LINE; THREE DIMENSIONAL CELL CULTURE; TUMOR SPHEROID; TWO DIMENSIONAL CELL CULTURE; WART VIRUS; ANIMAL; CELL CULTURE TECHNIQUE; CHEMISTRY; PROCEDURES; TISSUE ENGINEERING;

ANIMALS; BIOLOGICAL PRODUCTS; CELL CULTURE TECHNIQUES; COCULTURE TECHNIQUES; HUMANS; TISSUE ENGINEERING;

EID: 84957105975     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666151002114227     Document Type: Review

References (140)

1. Wolffe AP, Tata JR. Primary culture, cellular stress and differentiated function. FEBS Lett 1984; 176(1): 8-15.
2. Wakabayashi Y, Chua J, Larkin JM, Lippincott-Schwartz J, Arias IM. Four-dimensional imaging of filter-grown polarized epithelial cells. Histochem Cell Biol 2007; 127(5): 463-72.
3. Mackie EJ, Loh LH, Sivagurunathan S, et al. Protease-activated receptors in the musculoskeletal system. Int J Biochem Cell Biol 2008; 40(6-7): 1169-84.
4. van Deursen JM. The role of senescent cells in ageing. Nature 2014; 509(7501): 439-46.
5. Liu K, Wang K, Yan H. Incomplete digestion preserves chondrocytes from dedifferentiating in long-termed culture on plastic substrate. Tissue Cell 2009; 41(1): 1-11.
6. Danhier P, Copetti T, De Preter G, et al. Influence of cell detachment on the respiration rate of tumor and endothelial cells. PLoS One 2013; 8(1): e53324.
7. Manira M, Khairul Anuar K, Seet WT, et al. Comparison of the effects between animal-derived trypsin and recombinant trypsin on human skin cells proliferation, gene and protein expression. Cell Tissue Bank 2014; 15(1): 41-9.
8. Menssen HD, Herlyn M, Rodeck U, Koprowski H. Rapid dissociation of adherent human tumor cells by ultrasound. J Immunol Methods 1987; 104(1-2): 1-6.
9. Batista U, Garvas M, Nemec M, Schara M, Veranic P, Koklic T. Effects of different detachment procedures on viability, nitroxide reduction kinetics and plasma membrane heterogeneity of V-79 cells. Cell Biol Int 2010; 34(6): 663-8.
10. Mahabadi S, Labeed FH, Hughes MP. The effects of cell detachment methods on the dielectric properties of adherent and suspension cells. Electrophoresis 2015.
11. Canavan HE, Cheng X, Graham DJ, Ratner BD, Castner DG. Cell sheet detachment affects the extracellular matrix: a surface science study comparing thermal liftoff, enzymatic, and mechanical methods. J Biomed Mater Res A 2005; 75(1): 1-13.
12. Liu W, Moulay M, Willenbrock S, et al. Comparative characterization of stem cell marker expression, metabolic activity and resistance to doxorubicin in adherent and spheroid cells derived from the canine prostate adenocarcinoma cell line CT1258. Anticancer Res 2015; 35(4): 1917-27.
13. Fey SJ, Wrzesinski K. Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line. Toxicol Sci 2012; 127(2): 403-11.
14. Ramaiahgari SC, den Braver MW, Herpers B, et al. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liverlike properties for repeated dose high-throughput toxicity studies. Arch Toxicol 2014; 88(5): 1083-95.
15. Wrzesinski K, Magnone MC, Visby Hansen L, et al. HepG2/C3A 3D spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation. Toxicol Res 2013; 2(3): 163-72.
16. Messner S, Agarkova I, Moritz W, Kelm JM. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 2013; 87(1): 209-13.
17. Piccinini F, Tesei A, Arienti C, Bevilacqua A. Cancer multicellular spheroids: volume assessment from a single 2D projection. Comput Methods Programs Biomed 2015; 118(2): 95-106.
18. Price AM, Luftig MA. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation. Adv Virus Res 2014; 88: 279-313.
19. Ahuja D, Saenz-Robles MT, Pipas JM. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 2005; 24(52): 7729-45.
20. Thomas P, Smart TG. HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 2005; 51(3): 187-200.
21. Donato MT, Jover R, Gomez-Lechon MJ. Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. Curr Drug Metab 2013; 14(9): 946-68.
22. Cai Y, Mikkelsen JG. Driving DNA transposition by lentiviral protein transduction. Mob Genet Elements 2014; 4: e29591.
23. Amit M. Sources and derivation of human embryonic stem cells. Methods Mol Biol 2013; 997: 3-11.
24. Hirschi KK, Li S, Roy K. Induced pluripotent stem cells for regenerative medicine. Annu Rev Biomed Eng 2014; 16: 277-94.
25. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 2008; 15(2): 109-16.
26. Puliafito A, Hufnagel L, Neveu P, et al. Collective and single cell behavior in epithelial contact inhibition. Proc Natl Acad Sci USA 2012; 109(3): 739-44.
27. Sun H, Chow EC, Liu S, Du Y, Pang KS. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol 2008; 4(4): 395-411.
28. Sarmento B, Andrade F, da Silva SB, Rodrigues F, das Neves J, Ferreira D. Cell-based in vitro models for predicting drug permeability. Expert Opin Drug Metab Toxicol 2012; 8(5): 607-21.
29. Jensen PK, Fey SJ, Larsen PM, Norgard JO, Bolund L. Morphological differentiation and changes in polypeptide synthesis pattern during regeneration of human epidermal tissue developed in vitro. Differentiation 1991; 47(1): 37-48.
30. Ali N, Hosseini M, Vainio S, Taieb A, Cario-Andre M, Rezvani HR. Skin Equivalents: Skin from Reconstructions as Models to Study Skin Development & Diseases. Br J Dermatol 2015; 173(2): 391-403.
31. Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 2014; 15(12): 786-801.
32. Kutys ML, Doyle AD, Yamada KM. Regulation of cell adhesion and migration by cell-derived matrices. Exp Cell Res 2013; 319(16): 2434-9.
33. Modepalli VN, Rodriguez AL, Li R, et al. In vitro response to functionalized self-assembled peptide scaffolds for three-dimensional cell culture. Biopolymers 2014; 102(2): 197-205.
34. Kharkar PM, Kiick KL, Kloxin AM. Designing degradable hydrogels for orthogonal control of cell microenvironments. Chem Soc Rev 2013; 42(17): 7335-72.
35. Grefte S, Vullinghs S, Kuijpers-Jagtman AM, Torensma R, Von den Hoff JW. Matrigel, but not collagen I, maintains the differentiation capacity of muscle derived cells in vitro. Biomed Mater 2012; 7(5): 055004.
36. Verhulsel M, Vignes M, Descroix S, Malaquin L, Vignjevic DM, Viovy JL. A review of microfabrication and hydrogel engineering for micro-organs on chips. Biomaterials 2014; 35(6): 1816-32.
37. Hosseinkhani M, Mehrabani D, Karimfar MH, Bakhtiyari S, Manafi A, Shirazi R. Tissue engineered scaffolds in regenerative medicine. World J Plast Surg 2014; 3(1): 3-7.
38. Peickert S, Waurig J, Dittfeld C, et al. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo. Lab Invest 2012; 92(11): 1607-22.
39. Pease JC, Brewer M, Tirnauer JS. Spontaneous spheroid budding from monolayers: a potential contribution to ovarian cancer dissemination. Biol Open 2012; 1(7): 622-8.
40. Vinci M, Gowan S, Boxall F, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 2012; 10: 29.
41. Morris JE, Potter SW, Rynd LS, Buckley PM. Adhesion of mouse blastocysts to uterine epithelium in culture: a requirement for mutual surface interactions. J Exp Zool 1983; 225(3): 467-79.
42. Terrasso AP, Pinto C, Serra M, et al. Novel scalable 3D cell based model for in vitro neurotoxicity testing: combining human differentiated neurospheres with gene expression and functional endpoints. J Biotechnol 2015; 205: 82-92.
43. Schwarz RP, Goodwin TJ, Wolf DA. Cell culture for threedimensional modeling in rotating-wall vessels: an application of simulated microgravity. J Tissue Cult Methods 1992; 14(2): 51-7.
44. Goodwin TJ, Prewett TL, Wolf DA, Spaulding GF. Reduced shear stress: a major component in the ability of mammalian tissues to form three-dimensional assemblies in simulated microgravity. J Cell Biochem 1993; 51(3): 301-11.
45. Wang AZ, Ojakian GK, Nelson WJ. Steps in the morphogenesis of a polarized epithelium. I. Uncoupling the roles of cell-cell and cellsubstratum contact in establishing plasma membrane polarity in multicellular epithelial (MDCK) cysts. J Cell Sci 1990; 95(Pt 1): 137-51.
46. Guo Q, Xia B, Moshiach S, et al. The microenvironmental determinants for kidney epithelial cyst morphogenesis. Eur J Cell Biol 2008; 87(4): 251-66.
47. Zhang Y, Yan W, Chen X. P63 regulates tubular formation via epithelial-to-mesenchymal transition. Oncogene 2014; 33(12): 1548-57.
48. Soriano FG, Barbeiro HV, Barbeiro DF. Inflammatory response: role of B1 cells. Shock 2013; 39 (Suppl 1): 5-9.
49. Kwon SH, Nedvetsky PI, Mostov KE. Transcriptional profiling identifies TNS4 function in epithelial tubulogenesis. Curr Biol 2011; 21(2): 161-6.
50. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005; 5(9): 675-88.
51. Kushida A, Yamato M, Konno C, Kikuchi A, Sakurai Y, Okano T. Temperature-responsive culture dishes allow nonenzymatic harvest of differentiated Madin-Darby canine kidney (MDCK) cell sheets. J Biomed Mater Res 2000; 51(2): 216-23.
52. Yonemura S. Differential sensitivity of epithelial cells to extracellular matrix in polarity establishment. PLoS One 2014; 9(11): e112922.
53. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 2003; 30(3): 256-68.
54. Whyte J, Thornton L, McNally S, et al. PKCzeta regulates cell polarisation and proliferation restriction during mammary acinus formation. J Cell Sci 2010; 123(Pt 19): 3316-28.
55. Biazik JM, Jahn KA, Su Y, Wu YN, Braet F. Unlocking the ultrastructure of colorectal cancer cells in vitro using selective staining. World J Gastroenterol 2010; 16(22): 2743-53.
56. Chartier NT, Laine MG, Ducarouge B, et al. Enterocytic differentiation is modulated by lipid rafts-dependent assembly of adherens junctions. Exp Cell Res 2011; 317(10): 1422-36.
57. Ferruzza S, Rossi C, Scarino ML, Sambuy Y. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serumcontaining medium. Toxicol In Vitro 2012; 26(8): 1252-5.
58. Buhrke T, Lengler I, Lampen A. Analysis of proteomic changes induced upon cellular differentiation of the human intestinal cell line Caco-2. Develop Growth Diff 2011; 53(3): 411-26.
59. Verzi MP, Shin H, He HH, et al. Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Develop Cell 2010; 19(5): 713-26.
60. Bouchard V, Demers MJ, Thibodeau S, et al. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol 2007; 212(3): 717-28.
61. Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 2010; 107(8): 3722-7.
62. Kinasiewicz A, Gautier A, Lewiska D, Smietanka A, Legallais C, Werynski A. Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver. Int J Artificial Organs 2008; 31(4): 340-7.
63. Wrzesinski K, Fey SJ. After trypsinisation, 3D spheroids of C3A hepatocytes need 18 days to re-establish similar levels of key physiological functions to those seen in the liver. Toxicol Res 2013; 2(2): 123-35.
64. Guillouzo A, Guguen-Guillouzo C. Evolving concepts in liver tissue modeling and implications for in vitro toxicology. Expert Opin Drug Metab Toxicol 2008; 4(10): 1279-94.
65. Rebelo SP, Costa R, Estrada M, Shevchenko V, Brito C, Alves PM. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism. Arch Toxicol 2015; 89(8): 1347-58.
66. Zhang RR, Takebe T, Miyazaki L, et al. Efficient hepatic differentiation of human induced pluripotent stem cells in a threedimensional microscale culture. Methods Mol Biol 2014; 1210: 131-41.
67. Gieseck RL, 3rd, Hannan NR, Bort R, et al. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS One 2014; 9(1): e86372.
68. Kaneuji T, Ariyoshi W, Okinaga T, Toshinaga A, Takahashi T, Nishihara T. Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. Biochem Biophys Res Commun 2011; 408(1): 103-9.
69. Jia YY, Li F, Geng N, et al. Fluid flow modulates the expression of genes involved in the Wnt signaling pathway in osteoblasts in 3D culture conditions. Int J Mol Med 2014; 33(5): 1282-8.
70. Xiao L, Kumazawa Y, Okamura H. Cell death, cavitation and spontaneous multi-differentiation of dental pulp stem cells-derived spheroids in vitro: a journey to survival and organogenesis. Biol Cell 2014; 106(12): 405-19.
71. Chang TT, Hughes-Fulford M. Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng Part 2009; 15(3): 559-67.
72. Wrzesinski K, Rogowska-Wrzesinska A, Kanlaya R, et al. The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments. PLoS One 2014; 9(9): e106973.
73. Dixon JR, Jung I, Selvaraj S, et al. Chromatin architecture reorganization during stem cell differentiation. Nature 2015; 518(7539): 331-6.
74. Stevanato L, Sinden JD. The effects of microRNAs on human neural stem cell differentiation in two-and three-dimensional cultures. Stem Cell Res Ther 2014; 5(2): 49.
75. Cui Y, Xiao Z, Chen T, et al. The miR-7 identified from collagen biomaterial-based three-dimensional cultured cells regulates neural stem cell differentiation. Stem Cells Dev 2014; 23(4): 393-405.
76. Grun B, Benjamin E, Sinclair J, et al. Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Prolif 2009; 42(2): 219-28.
77. Rajcevic U, Knol JC, Piersma S, et al. Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture. Proteome Sci 2014; 12: 39.
78. Rogowska-Wrzesinska A, Wrzesinski K, Fey SJ. Heteromer scoreusing internal standards to assess the quality of proteomic data. Proteomics 2014; 14(9): 1042-7.
79. Ingeson-Carlsson C, Nilsson M. Switching from MAPK-dependent to MAPK-independent repression of the sodium-iodide symporter in 2D and 3D cultured normal thyroid cells. Mol Cell Endocrinol 2013; 381(1-2): 241-54.
80. Lin S, Mequanint K. The role of Ras-ERK-IL-1beta signaling pathway in upregulation of elastin expression by human coronary artery smooth muscle cells cultured in 3D scaffolds. Biomaterials 2012; 33(29): 7047-56.
81. Jordanova A, Stefanova N, Staneva G, Pankov R, Momchilova A, Lalchev Z. Surface properties and behavior of lipid extracts from plasma membranes of cells cultured as monolayer and in tissue-like conditions. Cell Biochem Biophys 2009; 54(1-3): 47-55.
82. Walters WP. Going further than Lipinski's rule in drug design. Expert Opin Drug Discov 2012; 7(2): 99-107.
83. Williams HD, Trevaskis NL, Charman SA, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev 2013; 65(1): 315-499.
84. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 2010; 148(1): 3-15.
85. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroidbased drug screen: considerations and practical approach. Nat Protocols 2009; 4(3): 309-24.
86. Arisi MF, Starker RA, Addya S, Huang Y, Fernandez SV. All transretinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells. Int J Oncol 2014; 44(6): 1831-42.
87. Tai J, Cheung SS, Ou D, Warnock GL, Hasman D. Antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids. Phytomedicine 2014; 21(4): 506-14.
88. Ellinger B, Silber J, Prashar A, et al. A phenotypic screening approach to identify anticancer compounds derived from marine fungi. Assay Drug Dev Technol 2014; 12(3): 162-75.
89. Howes AL, Richardson RD, Finlay D, Vuori K. 3-Dimensional culture systems for anti-cancer compound profiling and highthroughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems. PLoS One 2014; 9(9): e108283.
90. Lama R, Zhang L, Naim JM, Williams J, Zhou A, Su B. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing. Bioorg Med Chem 2013; 21(4): 922-31.
91. Ashley N, Jones M, Ouaret D, Wilding J, Bodmer WF. Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalized therapeutic assays. J Pathol 2014; 234(1): 34-45.
92. Niu Y, Bai J, Kamm RD, Wang Y, Wang C. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment. Mol Pharm 2014; 11(7): 2022-9.
93. Hirschhaeuser F, Leidig T, Rodday B, Lindemann C, Mueller-Klieser W. Test system for trifunctional antibodies in 3D MCTS culture. J Biomol Screen 2009; 14(8): 980-90.
94. Voros A, Kormos B, Valyi-Nagy T, Valyi-Nagy K. Increased resistance of breast, prostate, and embryonic carcinoma cells against herpes simplex virus in three-dimensional cultures. ISRN Oncol 2013; 2013: 104913.
95. Hogk I, Rupp S, Burger-Kentischer A. 3D-tissue model for herpes simplex virus-1 infections. Methods Mol Biol 2013; 1064: 239-51.
96. Sainz B, Jr., TenCate V, Uprichard SL. Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection. Virol J 2009; 6: 103.
97. Sainz B, Jr., Barretto N, Yu X, Corcoran P, Uprichard SL. Permissiveness of human hepatoma cell lines for HCV infection. Virol J 2012; 9: 30.
98. Aly HH, Shimotohno K, Hijikata M. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV. Biochem Biophys Res Commun 2009; 379(2): 330-4.
99. Gohda J, Ma Y, Huang Y, Zhang Y, Gu L, Han Y, et al. HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro. Retrovirology 2015; 12: 12.
100. Ryndock EJ, Biryukov J, Meyers C. Replication of human papillomavirus in culture. Methods Mol Biol 2015; 1249: 39-52.
101. Fey SJ, Larsen PM. DNA viruses and human cancer. Cancer Lett 1988; 41(1): 1-19.
102. Vinokurova S, von Knebel Doeberitz M. Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One 2011; 6(9): e24451.
103. Pinheiro C, Garcia EA, Morais-Santos F, et al. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer 2014; 14: 751.
104. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulat Toxicol Pharmacol 2000; 32(1): 56-67.
105. Lin Z, Will Y. Evaluation of drugs with specific organ toxicities in organ-specific cell lines. Toxicol Sci 2012; 126(1): 114-27.
106. Liu M, Howes A, Lesperance J, et al. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Cancer Res 2005; 65(12): 5325-36.
107. Barbone D, Yang TM, Morgan JR, Gaudino G, Broaddus VC. Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem 2008; 283(19): 13021-30.
108. Howes AL, Chiang GG, Lang ES, et al. The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures. Mol Cancer Ther 2007; 6(9): 2505-14.
109. Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010; 31(32): 8494-506.
110. Fey SJ, Wrzesinski K. Determination of acute lethal and chronic lethal dose thresholds of valproic acid using 3D spheroids constructed from the immortal human hepatocyte cell line HepG2/C3A 2013. In: Valproic Acid [Internet]. New York: Nova Science Publishers, Inc.; 2013; pp. 65-141.
111. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4(6): 489-99.
112. Khetani SR, Kanchagar C, Ukairo O, et al. Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans. Toxicol Sci 2013; 132(1): 107-17.
113. Materne EM, Ramme AP, Terrasso AP, et al. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. J Biotechnol 2015; 205: 36-46.
114. Ruan X, Shen C, Meng Q. Establishment of a methodology for investigating protectants against ethanol-induced hepatotoxicity. Food Chem Toxicol 2010; 48(5): 1145-51.
115. Ramappa V, Aithal GP. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol 2013; 3(1): 37-49.
116. Li F, Lu J, Cheng J, et al. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat Med 2013; 19(4): 418-20.
117. Stevens JL, Baker TK. The future of drug safety testing: expanding the view and narrowing the focus. Drug Discov Today 2009; 14(3-4): 162-7.
118. Ferri N, Siegl P, Corsini A, Herrmann J, Lerman A, Benghozi R. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. Pharmacol Ther 2013; 138(3): 470-84.
119. Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010; 9(3): 203-14.
120. Beauchamp P, Moritz W, Kelm JM, et al. Development and characterization of a scaffold-free 3D spheroid model of induced pluripotent stem cell-derived human cardiomyocytes. Tissue Eng Part C Methods 2015; 21(8): 852-61.
121. Di Pasquale E, Lodola F, Miragoli M, et al. CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Disease 2013; 4: e843.
122. Walsh KB. Targeting cardiac potassium channels for state-of-theart drug discovery. Expert Opin Drug Discov 2015; 10(2): 157-69.
123. Mihic A, Li J, Miyagi Y, et al. The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cellderived cardiomyocytes. Biomaterials 2014; 35(9): 2798-808.
124. Nichols JE, Niles JA, Vega SP, Argueta LB, Eastaway A, Cortiella J. Modeling the lung: Design and development of tissue engineered macro-and micro-physiologic lung models for research use. Exp Biol Med (Maywood) 2014; 239(9): 1135-69.
125. Ekert JE, Johnson K, Strake B, et al. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development. PLoS One 2014; 9(3): e92248.
126. Cook D, Brown D, Alexander R, et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework. Nat Rev Drug Discov 2014; 13(6): 419-31.
127. Huang JX, Blaskovich MA, Cooper MA. Cell-and biomarkerbased assays for predicting nephrotoxicity. Expert Opin Drug Metab Toxicol 2014; 10(12): 1621-35.
128. Zhang H, Lau SF, Heng BF, et al. Generation of easily accessible human kidney tubules on two-dimensional surfaces in vitro. J Cell Mol Med 2011; 15(6): 1287-98.
129. Xia Y, Sancho-Martinez I, Nivet E, Rodriguez Esteban C, Campistol JM, Izpisua Belmonte JC. The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells. Nat Prot 2014; 9(11): 2693-704.
130. Cunha C, Panseri S, Villa O, Silva D, Gelain F. 3D culture of adult mouse neural stem cells within functionalized self-assembling peptide scaffolds. Int J Nanomed 2011; 6: 943-55.
131. Morimoto Y, Kato-Negishi M, Onoe H, Takeuchi S. Threedimensional neuron-muscle constructs with neuromuscular junctions. Biomaterials 2013; 34(37): 9413-9.
132. Dutt K, Harris-Hooker S, Ellerson D, Layne D, Kumar R, Hunt R. Generation of 3D retina-like structures from a human retinal cell line in a NASA bioreactor. Cell Transpl 2003; 12(7): 717-31.
133. Thoma CR, Stroebel S, Rosch N, Calpe B, Krek W, Kelm JM. A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications. J Biomol Screen 2013; 18(10): 1330-7.
134. Jo YH, Jang IJ, Nemeno JG, et al. Artificial islets from hybrid spheroids of three pancreatic cell lines. Transpl Proc 2014; 46(4): 1156-60.
135. Schanz J, Pusch J, Hansmann J, Walles H. Vascularised human tissue models: a new approach for the refinement of biomedical research. J Biotechnol 2010; 148(1): 56-63.
136. Maschmeyer I, Lorenz AK, Schimek K, et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 2015; 15(12): 2688-99.
137. Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing. Toxicol Res (Camb) 2013; 2(1): 23-39.
138. Lipps C, May T, Hauser H, Wirth D. Eternity and functionality-rational access to physiologically relevant cell lines. Biol Chem 2013; 394(12): 1637-48.
139. Greaves M. When one mutation is all it takes. Cancer cell 2015; 27(4): 433-4.
140. Want AJ, Nienow AW, Hewitt CJ, Coopman K. Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask. Regen Med 2012; 7(1): 71-84.